🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Check out this recent interview featuring our CEO, John Lepore with @brandloncar of @BiotechTVHQ discussing how we're exploring the #ExpandedProteome to unveil new drugs and drug targets to develop potential first-in-class medicines for patients.

At ProFound, we're a team of pioneers dedicated to our #ProFoundPurpose of illuminating the #ExpandedProteome to unlock new therapeutic possibilities for patients. Visit our careers page for open opportunities to make a profound impact on human health: bit.ly/3ZPH5NX

Next week, our CEO, John Lepore, will be moderating a panel at the Longwood Healthcare Leaders #BostonCEO meeting. Stop by the panel to hear insights from industry experts on accelerating the translation of science into medicine. More details about the panel here: bit.ly/3Y8pgbF

Our industrialized application of RiboSeq technology at scale identifies proteins actively being translated by the ribosome by taking a snapshot of #RNA translation, discovering novel proteins in primary human tissues quickly, accurately. More: bit.ly/4aV1Klr

We had an amazing time at the Boston Business Journal #40Under40 ceremony, celebrating our very own Vinidhra Mani as one of Boston's rising leaders making a real impact. Congratulations, Vini, on this incredible accomplishment!

🎉 Exciting news! We’re thrilled to announce that we have been recognized as a 2025 @BioSpace Best Places to Work. A huge thank you to our incredibly talented and dedicated team for making this achievement possible. Together, we’re shaping the future for patients. #ProFoundPeople

Harnessing insights from our ever-expanding database, we leverage our ProFoundry™ Atlas to predict the function & therapeutic relevance of new proteins we uncover within the #ExpandedProteome. Learn how we are unlocking a new universe of possibilities: bit.ly/4aV1Klr

2024 was a year of significant milestones for us at ProFound. We’re grateful for our dedicated team members and valued partners for making these accomplishments possible. Here’s to a bright and innovative year ahead!

#HappyHolidays from all of us at ProFound Therapeutics! We look forward to spending this time reflecting on the personal and professional accomplishments from the last year and cherishing moments with loved ones. Wishing everyone a joyful and restful holiday season!

As Noubar Afeyan shared in Flagship Pioneering’s annual letter, “we founded ProFound Therapeutics to interrogate what was once deemed ‘junk,’ revealing a vastly expanded human proteome that includes thousands of previously undiscovered proteins.” Access the letter at the link below.

Our CEO, John Lepore, MD, shared the latest on the ProFoundry platform, thoughts on how the company is prioritizing targets that have the potential to become meaningful medicines & plans for the year ahead in a CEO Chat with Flagship Pioneering: bit.ly/4hwup4a #JPM25

Scientists at ProFound and beyond are uncovering the hidden universe of 'dark proteins'—overlooked proteins that could play key roles in human disease. These discoveries expand the horizon for #DrugDevelopment, and we’re excited about their potential. Read more in nature:

On the International Day of Women and Girls in Science, we honor the women shaping the future of healthcare through innovation and dedication. Members of the ProFound team shared advice for aspiring #WomenInScience. Learn more about our team: bit.ly/4bDe0aZ #February11

What does 2025 hold for biopharma? We’re most excited about new insights into the #HumanGenome that may drive opportunities for novel drug target identification & validation. Read more from our CEO John Lepore in Scrip, Citeline Commercial Scrip Asks series: bit.ly/3XbMvRm

At ProFound, we’re unlocking the vast potential of the expanded human proteome. Our breakthroughs are reshaping how we view the genome, enabling new possibilities for first-in-class treatments. Learn more about us: bit.ly/3Fse96A

Listen to our CEO, John Lepore, on @SanoGenetics' #TheGeneticsPodcast with Patrick Short to learn more about ProFound’s strategy for identifying the most promising drug or drug targets from the #ExpandedProteome. 🎧 bit.ly/3Y06y5s

What if many ‘non-coding’ RNAs could produce functional proteins? This question fueled development of the ProFoundry™ Platform to rapidly discover and implicate novel proteins in disease. Learn more here: bit.ly/4bDe0aZ

Our CEO, John Lepore, is moderating a panel discussion at the Longwood Healthcare Leaders #MiamiCEO meeting where panelists will share expert insights on emerging trends on partnerships and the future of deal-making in biopharma. Details: bit.ly/425tPFL #longwoodhealthcareleaders

#NationalDNADay marks the completion of the #HumanGenomeProject. At ProFound, we’re building on that legacy—uncovering novel proteins encoded by previously undefined regions of the genome with vast therapeutic potential. More here: bit.ly/4aV1Klr

Join our CEO, John Lepore, MD, as he takes the stage at #BIO2025 alongside fellow industry leaders to explore how Nobel Prize-winning science can translate into real world therapies to tackle pressing health challenges. Learn more about the panel: bit.ly/4kCJt2d